Neurogene NGNE
NASDAQ NGNE
$25.65 -0.90 (-3.39%)
At close: Oct 2, 2026 · 4:00 PM EDT

Neurogene (NGNE) Return on Sales [ROS] (2018 - 2025)

Updated

Neurogene (NGNE) recorded Return on Sales [ROS] of -10345.08% in Q2 2025, down 8168.43 percentage points from -2176.65% a year earlier.

Analysis

Neurogene (NGNE) Return on Sales [ROS] (2018 - 2025) Analysis & Trends

For FY2024, Neurogene reported Return on Sales [ROS] of -8930.27%.

  • Annual Return on Sales [ROS] has a five-year change of -8923.17 percentage points (FY2019 to FY2024).
  • The Q2 2025 figure is the lowest quarterly Return on Sales [ROS] in data going back to Q2 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 Neurogene 578.46 Mn 578.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -10,345.08%
Dec 31, 2024 -8,930.27%
Sep 30, 2024 -8,197.41%
Jun 30, 2024 -2,176.65%
Dec 31, 2023 -5.56%
Sep 30, 2023 -5.25%
Jun 30, 2023 -5.09%
Sep 30, 2019 -5.95%
Jun 30, 2018 10.76%
API Access

Neurogene Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=NGNE&period=max&api_key=YOUR_API_KEY